World Of Taxonomy
25682-025Level 3

Ultomiris (ravulizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** RAVULIZUMAB

**Strength:** 300 mg/3mL

**Dosage form:** Solution, Concentrate

**Route:** Intravenous

**Labeler:** Alexion Pharmaceuticals Inc.

**Marketing category:** BLA (BLA761108)

**Pharmacologic class:** Complement Inhibitor [EPC], Complement Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/25682-025
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.

25682-025 - Ultomiris (ravulizumab) - NDC - World Of Taxonomy | World Of Taxonomy